Regulatory Training for Medical Device Companies

FDA generally classifies medical devices into Class I, Class II, and Class III based on risk and the level of regulatory control needed to assure safety and effectiveness. Class I devices are typically lower risk, Class II devices usually require additional controls and often a 510(k), and Class III devices usually require the highest level of review, often through PMA. Training helps teams understand how classification affects documentation, testing, and submission strategy.

21 CFR Part 820.25 requires manufacturers to have sufficient personnel with the necessary education, background, training, and experience to ensure activities are correctly performed. It also requires training to be documented and, where appropriate, for personnel to understand defects that may occur from improper performance of their jobs. In practice, this means medical device companies need structured training programs, current records, and role-specific competency support.

Regulatory training helps employees understand the requirements tied to their roles, from document control and design controls to complaint handling and audit support. Strong training reduces preventable errors, improves consistency across departments, and supports inspection readiness. It also helps companies maintain defensible training records and demonstrate that personnel performing quality-critical tasks are qualified and current on applicable procedures and regulations.

Training should extend beyond the regulatory team. Quality, engineering, clinical, manufacturing, document control, software, labeling, and post-market personnel may all need role-specific instruction depending on their responsibilities. Managers and executives also benefit from governance-level training. A strong program maps training to job functions so each employee understands the regulations, procedures, and quality expectations directly tied to the work they perform.

Common topics include FDA requirements, ISO 13485, ISO 14971, design controls, CAPA, complaint handling, document control, training record management, internal audits, labeling, submission readiness, and post-market obligations. For some companies, training may also cover EU MDR, Health Canada, TGA, SaMD, or IVD-specific requirements. The most effective programs focus on the regulations that apply to the company’s products, markets, and internal processes.

Training should occur during onboarding, when procedures or regulations change, when responsibilities shift, and at defined periodic intervals for refresher purposes. Companies should also retrain after audit findings, CAPA actions, or process updates that affect compliance-critical work. A sustainable training system links training frequency to document revisions, risk, and job responsibilities so records remain current and personnel stay aligned with the latest approved practices.

Yes. Auditors and inspectors routinely review whether personnel are trained, whether records are complete, and whether employees can explain the procedures they follow. Effective training improves both documentation and real-world execution. It helps teams answer questions consistently, follow approved processes correctly, and avoid common findings related to outdated records, incomplete qualifications, or weak understanding of quality system responsibilities.

Training documentation should clearly identify the employee, training topic, applicable procedure or regulation, training date, trainer or delivery method, and completion status. Many companies also document competency checks or effectiveness measures for critical roles. Records should be controlled, retrievable, and linked to current document versions where applicable. This creates an auditable trail showing that personnel were trained appropriately before performing regulated activities.